How Your Kidneys Handle a New Diabetes Medicine
Part of Hormones & metabolism clinical trials.
This study tests how a new injectable medicine called HDM1005 works in your body, with special attention to how your kidneys process it. Researchers want to understand if the medicine is safe for people with kidney problems and healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female
- Have a BMI (body mass index) between 19 and 35
- If you have kidney disease, it must be chronic (long-term) and not due to blocked urine flow or recent kidney injury
- No history of medullary thyroid cancer, thyroid growths, or MEN2 syndrome
- No severe or frequent low blood sugar episodes in the past 3 months, no recent pancreas or gallbladder problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new medication (HDM1005) affects the way your body absorbs and processes common drugs like metformin, atorvastatin, warfarin, and digoxin. It is for healthy volunteers to understand potential interactions before further testing.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This trial tests an investigational drug called HDM1005 for people with type 2 diabetes whose blood sugar is still high despite taking metformin (with or without another diabetes pill called an SGLT2 inhibitor). The goal is to see if the new drug can better lower blood sugar levels.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests how a new medicine, HDM1002, interacts with four common drugs (repaglinide, atorvastatin, digoxin, rosuvastatin) in healthy and overweight adults. The results will help guide safe dosing for future patients.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.